Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Current update and testing procedures for genetic diagnosis in malignant neoplasm: additional information on pathological tests].

Rinsho byori. The Japanese journal of clinical pathology - 1 Feb 2010

Funato Tadao, Takeda Mayu

Abstract excerpt

Targeted therapy refers to anticancer treatment which specifically targets key molecules of cancer cells. The higher levels of expression of the epidermal growth factor receptor (EGFR) have also been shown to be correlated with non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC). Poten...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Cetuximab
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gefitinib

Share to Genes, ras

Share to Molecular Diagnostic Techniques

Share to Quality Control

Share to Quinazolines

Source

Identifiers

PMID: 20229816

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20229816-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Current update and testing procedures for genetic diagnosis in malignant neoplasm: additional information on pathological tests].PMID 20229816Read ↗

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

The molecular pathology of cancer.Semantic proximity Read ↗

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

Companion diagnostic testing for targeted cancer therapies: an overview.Semantic proximity Read ↗

[The molecular diagnosis of cancer].Semantic proximity Read ↗

The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC.Semantic proximity Read ↗

[NSCLC and new oncogenic mutations: Diagnosis and perspectives].Semantic proximity Read ↗

Food and Drug Administration approval of cetuximab and a new KRAS genetic test for metastatic colorectal cancer: major advance but just the tip of the biomarker iceberg.Semantic proximity Read ↗

[Update on new techniques for the molecular diagnosis of cancer].Semantic proximity Read ↗

Mutation detection and molecular targeted tumor therapiesSemantic proximity Read ↗

[Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.